Immoderate inhibition of estrogen by anastrozole enhances the severity of experimental polyarthritis

Experimental Gerontology

Volumn 44, Issue 6-7, 2009, Pages 398-405

  Jingxuan, Wang ^a   Qingyuan, Zhang ^a   Shi, Jin ^a   Meiyan, Feng ^a   Xinmei, Kang ^a   Shu, Zhao ^a   Shuling, Liu ^a   Wenhui, Zhao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Aromatase inhibitors; Arthralgia; Arthritis; Breast cancer; Immune

Indexed keywords

ANASTROZOLE; COLLAGEN TYPE 2; ESTROGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TAMOXIFEN; AROMATASE INHIBITOR; COLLAGEN; ESTROGEN RECEPTOR; NITRILE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRALGIA; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE EXACERBATION; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IMMUNOREGULATION; JOINT DESTRUCTION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; ANIMAL; ARTHRITIS; BREAST NEOPLASMS; CHEMICALLY INDUCED; DRUG EFFECTS; HUMAN; METABOLISM; OVARIECTOMY; SEVERITY OF ILLNESS INDEX; SPRAGUE DAWLEY RAT;

ANIMALS; AROMATASE INHIBITORS; ARTHRITIS; BREAST NEOPLASMS; COLLAGEN; ESTROGENS; FEMALE; HUMANS; NITRILES; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; SEVERITY OF ILLNESS INDEX; TRIAZOLES;

RATTUS;

EID: 67349182119     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2009.03.003     Document Type: Article

References (26)

1. Aleph P.G., and Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4+ CD25+ regulatory T cells by promoting their proliferation. Immunology 118 1 (2006) 58-65
2. ATAC Trialists' Group. Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365 (2005) 60-62
3. Benoit M., Hubert M., and Pierre M. Will steroidal aromatase inhibitors induce rheumatoid arthritis?. Ann. Rheum. Dis. 66 (2007) 557-558
4. Buzdar A.U. Aromatase inhibitors: changing the face of endocrine therapy for breast cancer. Breast Dis. 24 (2005) 107-117
5. Buzdar A.U., and On behalf of the ATAC Trialists' Group. Clinical features of joint symptoms observed in the 'arimidex', tamoxifen, alone or in combination (ATAC) trial. J. Clin. Oncol. 24 (2006) 551
6. Carlsten H. Immune responses and bone loss: the estrogen connection. Immunol. Rev. 208 (2005) 194-206
7. Coates A.S., Keshaviah A., Thurlimann B., Mouridsen H., Mauriac L., Forbes J.F., Paridaens R., Castiglione-Gertsch M., Gelber R.D., Colleoni M., Ldng I., Mastro L., Smith I., Chirgwin J., Nogaret J., Pienkowski T., Wardley A., Jakobsen E.H., and Price K.N. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J. Clin. Oncol. 25 (2007) 486-492
8. Cortés M., Canellada A., Miranda S., Dokmetjian J., and Gentile T. Placental secreted factors: their role in the regulation of anti-CII antibodies and amelioration of collagen induced arthritis in rats. Immunol. Lett. 119 1-2 (2008) 42-48
9. Croft P., Rigby A.S., Boswell R., Schollum J., and Silman A. The prevalence of chronic widespread pain in the general population. J. Rheumatol. 20 (1993) 710-713
10. De Clerck L. B lymphocytes and humoral immune responses in rheumatoid arthritis. Clin. Rheumatol. 14 (1995) 14-18
11. Felson D.T., and Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 41 (1998) 1343-1355
12. Fletcher D.S., Widmer W.R., Luell S., Christen A., Orevillo C., Shah S., and Visco D. Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats. J. Pharmacol. Exp. Ther. 284 (1998) 714-721
13. Geisler J., Anker G., Dowsett M., and Per L. Letrozole suppresses plasma estrogen levels in postmenopausal breast cancer patients more completely than anastrozole. Proc. Am. Soc. Clin. Oncol. 19 (2000) 102a
14. Geisler J., Haynes B., Anker G., Dowsett M., and Lonning P.E. Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J. Clin. Oncol. 20 (2002) 751-757
15. Goss P.E., and Strasser K. Aromatase inhibitors in the treatment and prevention of breast cancer. J. Clin. Oncol. 19 (2001) 881-894
16. Jansson L., and Holmdahl R. Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. Arthritis Rheum. 44 (2001) 2168-2175
17. Kannan K., Ortmann R.A., and Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 12 3 (2005) 167-181
18. Morgan M.E., Flierman R., Van Duivenvoorde L.M., Witteveen H.J., Van E.W., Van Laar J.M., De Vries R.R.P., and Toes R.E.M. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52 7 (2005) 2212-2221
19. Polanczyk M.J., Carson B.D., Subramanian S., Michael A., Arthur A.V., Steven F.Z., and Halina O. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cells compartment. J. Immunol. 173 (2004) 2227-2230
20. Su Z., and Stevenson M.M. IL-12 is required for antibody-mediated protective immunity against blood-stage plasmodiumchabaudi as malaria infection in mice. J. Immunol. 168 (2002) 1348-1355
21. Wang J.X., Zhang Q.Y., Jin S., He D.N., Zhao S., and Liu S.L. Genistein modulate immune responses in collagen-induced rheumatoid arthritis model. Maturitas 59 4 (2008) 405-412
22. Watanabe S., Uesugi S., and Kikuchi Y. Isoflavones for prevention of cancer, cardiovascular diseases, gynecological problems and possible immune potentiation. Biomed. Pharmacother. 56 (2002) 302-312
23. Watson W.C., and Townes A.S. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J. Exp. Med. 162 (1985) 1878-1891
24. Wolfe F., Ross K., Anderson J., Russell I.J., and Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 38 (1995) 19-28
25. Yamasaki D., Enokida M., Okano T., Hagino H., and Teshima R. Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis. Bone 28 (2001) 634-640
26. Zhao J., Li R., He J., Jin X.S., Li L., and Zhan G.L. Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells. Rheumatol. Int. 29 (2008) 9-16